How should I medically manage a patient with a non‑dilated gallbladder with normal wall thickness and a 3 mm echogenic polyp, right renal parenchymal calcification, and a post‑void residual urine volume of approximately 32% (121 cc after a 375 cc fill)?

Medical Management of 3mm Gallbladder Polyp with Renal Calcification and Elevated Post-Void Residual

For the 3mm gallbladder polyp, no follow-up imaging is required. 1

Gallbladder Polyp Management

Your patient has an extremely small (3mm) gallbladder polyp that falls well below any threshold for concern:

• Polyps ≤5mm have 0% malignancy risk across multiple large studies 1
• The 2022 Society of Radiologists in Ultrasound (SRU) consensus guidelines—the most authoritative current guidance—explicitly state that no follow-up is needed for polyps ≤9mm in the "extremely low risk" category 1
• In a survey of SRU fellows representing approximately 3 million gallbladder ultrasounds, there were zero documented cases of malignancy in polyps <10mm at initial detection or during follow-up 1
• Up to 83% of apparent polyps ≤5mm are not even found at subsequent cholecystectomy, suggesting many are imaging artifacts or transient findings 1

Action for gallbladder polyp: Reassure the patient. No imaging follow-up. No surgical referral.

Right Renal Parenchymal Calcification

This finding represents either:

• Nephrocalcinosis (calcium deposits within renal parenchyma)
• Small cortical calcifications from prior infection/infarction

Recommended evaluation:

• Serum creatinine and eGFR to assess renal function
• Serum calcium, phosphate, parathyroid hormone (PTH) to exclude hyperparathyroidism or metabolic causes
• Urinalysis to check for hematuria, proteinuria, or crystals
• 24-hour urine collection for calcium, oxalate, citrate, and uric acid if metabolic stone disease suspected
• Review medications that may cause nephrocalcinosis (loop diuretics, vitamin D excess, calcium supplements)

If asymptomatic with normal renal function and no metabolic abnormalities, this may simply require monitoring. If abnormalities are found, refer to nephrology.

Elevated Post-Void Residual (32% retention)

This is clinically significant and requires evaluation and treatment. 2

A post-void residual of 121cc out of 375cc (32%) is abnormally elevated. Normal PVR should be <50-100cc. This degree of retention suggests:

• Bladder outlet obstruction (most likely benign prostatic hyperplasia in men)
• Detrusor underactivity
• Neurogenic bladder

Immediate Evaluation Needed:

History to obtain:

• Lower urinary tract symptoms (LUTS): frequency, urgency, weak stream, hesitancy, nocturia, incomplete emptying
• International Prostate Symptom Score (IPSS) to quantify symptom severity and bother 2
• History of diabetes, neurological conditions (multiple sclerosis, Parkinson's, stroke), prior pelvic surgery
• Current medications (anticholinergics, opioids, decongestants that worsen retention)

Physical examination:

• Digital rectal exam to assess prostate size and consistency (if male patient)
• Pelvic exam to assess for prolapse (if female patient—stage ≥2 prolapse predicts elevated PVR) 3
• Neurological examination if neurogenic cause suspected

Additional testing:

• Uroflowmetry to assess maximum flow rate (Qmax <10-12 mL/sec suggests obstruction) 2
• Urinalysis and urine culture to exclude infection
• Serum creatinine to assess for hydronephrosis/renal impairment from chronic retention

Treatment Algorithm (assuming male patient with BPH):

First-line medical therapy: 2

• Alpha-blocker (tamsulosin 0.4mg daily, alfuzosin 10mg daily, or silodosin 8mg daily)
  • Provides rapid symptom relief (4-12 weeks)
  • Improves urinary flow and reduces PVR
  • Follow-up at 4-12 weeks with repeat IPSS and PVR measurement 2

If prostate >30cc on exam or ultrasound:

• Add 5-alpha reductase inhibitor (5-ARI) (finasteride 5mg daily or dutasteride 0.5mg daily)
  • Reduces prostate volume over 3-6 months
  • Combination therapy superior for larger prostates 2

If inadequate response or intolerable side effects:

• Consider alternative medical therapy or refer to urology for surgical intervention (TURP, laser procedures, etc.) 2

Critical Pitfall:

Do not start anticholinergic medications (for overactive bladder symptoms) in patients with elevated PVR >100-150cc, as this can precipitate acute urinary retention. The elevated PVR must be addressed first with alpha-blockers or surgical decompression 2, 3.

---

Summary Action Plan:

1. Gallbladder polyp: No action needed
2. Renal calcification: Check renal function, calcium/PTH panel, urinalysis
3. Elevated PVR: Start alpha-blocker, obtain IPSS, recheck PVR in 4-12 weeks, consider urology referral if no improvement